An Industry Survey With Focus on Cardiovascular Safety Pharmacology Study Design and Data Interpretation

View Full Paper

Ask AI

Bookmark

Why the study?

The Safety Pharmacology Society conducted an industry survey to examine current practices related mainly to cardiovascular safety pharmacology.

Population

Safety Pharmacology Society members

Design

Membership survey

Authors

Discussion

Survey reveals oncology dominance in CV safety pharmacology; leaves open how practices should adapt to novel agents.

Population

Members of the Safety Pharmacology Society (SPS) responding to an industry survey

Outcome

Industry practices related to nonclinical study design, data analysis methods, drug-induced effects, and conventional and novel CV assays

This survey provides a comprehensive overview of current industry practices and methodologies in cardiovascular safety pharmacology.

Authier et al. (2020) studied this question.

View Full Paper

Ask AI

Bookmark